iRhythm HoldingsIRTC -1.48%76 Return-on-Tangible-Asset is -5.51% as of Mar. 2026. GuruFocus rates IRTC with a GF Score™ of 76/100 and a GF Value™ of $163.87 (Modestly Undervalued). Among 854 Medical Devices & Instruments companies, iRhythm Holdings ranks worse than 56.79% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. iRhythm Holdings's annualizedNet Income for the quarter that ended in Mar. 2026 was $-55.7 Mil. iRhythm Holdings's average total tangible assets for the quarter that ended in Mar. 2026 was $1,012.3 Mil. Therefore, iRhythm Holdings's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was -5.51%.
The historical rank and industry rank for iRhythm Holdings's Return-on-Tangible-Asset or its related term are showing as below:
IRTC'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -40.48 Med: -23.03 Max: -2.83
Current: -2.83
During the past 12 years, iRhythm Holdings's highest Return-on-Tangible-Asset was -2.83%. The lowest was -40.48%. And the median was -23.03%.
IRTC's Return-on-Tangible-Asset is ranked worse than 56.79% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.595
vs IRTC: -2.83
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
iRhythm Holdings Return-on-Tangible-Asset Related Terms
iRhythm Holdings Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for iRhythm Holdings's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IRTC vs HAE, LIVN, ITGR: Return-on-Tangible-Asset Comparison
For the Medical Devices subindustry, iRhythm Holdings's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRhythm Holdings Return-on-Tangible-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRhythm Holdings's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where iRhythm Holdings's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of -5.51% mean?
iRhythm Holdings (IRTC) has a Return-on-Tangible-Asset of -5.51% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on iRhythm Holdings and its competitors. According to the industry distribution chart, iRhythm Holdings ranks #485 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 56.8%.
Is iRhythm Holdings' Return-on-Tangible-Asset too high?
iRhythm Holdings' current Return-on-Tangible-Asset is -5.51%. Based on the distribution chart, iRhythm Holdings ranks #485 out of 854 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, iRhythm Holdings has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRhythm Holdings' Return-on-Tangible-Asset compare to HAE and LIVN?
According to the Medical Devices & Instruments industry distribution chart, iRhythm Holdings ranks #485 out of 854 companies for Return-on-Tangible-Asset. This places iRhythm Holdings in the lower half of its industry. The industry median Return-on-Tangible-Asset is 0.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Medical Devices & Instruments company?
The median Return-on-Tangible-Asset among Medical Devices & Instruments companies is 0.60, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on iRhythm Holdings and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRhythm Holdings's current Return-on-Tangible-Asset is -5.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRhythm Holdings stock overvalued right now?
Based on GuruFocus' analysis, iRhythm Holdings (IRTC) is currently considered Modestly Undervalued. The stock's GF Value™ is $163.87, compared to a current price of $116.14 — trading 29.1% below its estimated fair value. The current Return-on-Tangible-Asset is -5.51%. iRhythm Holdings' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For iRhythm Holdings (IRTC), the current Return-on-Tangible-Asset is -5.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRhythm Holdings (IRTC) Overvalued in 2026?
Based on GuruFocus' analysis, iRhythm Holdings stock appears to be undervalued.
The current stock price of $116.14 is trading 29.1% below its estimated GF Value™ of $163.87.
GuruFocus considers iRhythm Holdings to be Modestly Undervalued.
Key valuation signals for IRTC:
Return-on-Tangible-Asset: -5.51%
GF Value™: $163.87 vs. price of $116.14 (29.1% below fair value)
No single metric tells the full story. See the IRTC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
76GF Score
Get the complete analysis for IRTC
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRTC has been successfully added to your 
